{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:05:53Z","timestamp":1790024753540,"version":"4.0.1"},"reference-count":68,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>With the recent outbreak of the COVID-19 pandemic and emergency use authorization of anti-SARS-CoV-2 vaccines, reports of post-vaccine immune thrombocytopenia (ITP) have gained attention. With this systematic review, we aim to analyze the clinical characteristics, therapeutic strategies, and outcomes of patients presenting with ITP after receiving COVID-19 vaccination. Medline, Embase, and Ebsco databases were systematically explored from inception until 1 June 2022. Case reports and case series investigating the association between the anti-SARS-CoV-2 vaccine and ITP were included. We found a total of 66 patients. The mean age of presentation was 63 years with a female preponderance (60.6%). Sixteen patients had pre-existing ITP. The mean time from vaccine administration to symptom onset was 8.4 days. More ITP events were triggered by mRNA vaccines (BNT162b2 (n = 29) &gt; mRNA-1273 (n = 13)) than with adenoviral vaccines (ChAdOx1-S AstraZeneca (n = 15) &gt; Ad26.COV2-S (n = 9)). Most of the patients were treated with steroids or IVIG, or both. The overall outcome was promising, with no reported deaths. Our review attempts to increase awareness among physicians while evaluating patients presenting with thrombocytopenia after receiving the vaccine. In our solicited opinion, the rarity of these events and excellent outcomes for patients should not change views regarding the benefits provided by immunization.<\/jats:p>","DOI":"10.3390\/vaccines10091444","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:19:01Z","timestamp":1662077941000},"page":"1444","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination"],"prefix":"10.3390","volume":"10","author":[{"given":"Prachi","family":"Saluja","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Amisha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmeen","family":"Goraya","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"ref_1","first-page":"273","article-title":"Idiopathic thrombocytopenic purpura (ITP)\u2014New era for an old disease","volume":"57","author":"Bumbea","year":"2019","journal-title":"Rom. J. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune Thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40164-021-00235-0","article-title":"COVID-19 vaccination associated severe immune thrombocytopenia","volume":"10","author":"Shah","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09537104.2011.633179","article-title":"Drug-induced immune thrombocytopenia: A descriptive survey in the French PharmacoVigilance database","volume":"23","author":"Moulis","year":"2011","journal-title":"Platelets"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajem.2021.05.054","article-title":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","volume":"49","author":"Long","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.thromres.2022.04.020","article-title":"Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases","volume":"214","author":"Saluja","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1097\/MJT.0000000000001431","article-title":"Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine","volume":"28","author":"Banerjee","year":"2021","journal-title":"Am. J. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1111\/bjh.17628","article-title":"Correspondence in reference to the previously published Epub manuscript: Immune thrombocytopenic purpura after SARS-CoV-2 vaccine","volume":"194","author":"Scanvion","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.17508","article-title":"Immune thrombocytopenic purpura after SARS-CoV-2 vaccine","volume":"194","author":"Candelli","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_12","first-page":"996","article-title":"Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19)","volume":"138","author":"Paulsen","year":"2021","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102615","DOI":"10.1016\/j.bcmd.2021.102615","article-title":"Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature","volume":"92","author":"Gardellini","year":"2021","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.3346\/jkms.2021.36.e306","article-title":"A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"36","author":"Kim","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e249237","DOI":"10.1136\/bcr-2022-249237","article-title":"Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine","volume":"15","author":"Sivaramakrishnan","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref_16","first-page":"1","article-title":"Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination","volume":"28","author":"Shalaby","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1136\/postgradmedj-2021-140947","article-title":"Acute immune thrombocytopenic purpura post first dose of COVID-19 vaccination","volume":"98","author":"Wong","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_18","first-page":"2580832","article-title":"Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two","volume":"2021","author":"Razzaq","year":"2021","journal-title":"Case Rep. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MBC.0000000000001082","article-title":"ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: Three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand","volume":"33","author":"Uaprasert","year":"2022","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Liao, P.-W., Teng, C.-L.J., and Chou, C.-W. (2021). Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection. Vaccines, 9.","DOI":"10.3390\/vaccines9121486"},{"key":"ref_21","first-page":"341","article-title":"Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine","volume":"23","author":"Ganzel","year":"2021","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1002\/ajh.26106","article-title":"Immune thrombocytopenia in a 22-year-old post COVID-19 vaccine","volume":"96","author":"Tarawneh","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e242220","DOI":"10.1136\/bcr-2021-242220","article-title":"Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination","volume":"14","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofab343","DOI":"10.1093\/ofid\/ofab343","article-title":"Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient with Previously Stable ITP","volume":"8","author":"Jawed","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e931478","DOI":"10.12659\/AJCR.931478","article-title":"A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination","volume":"22","author":"King","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e01344","DOI":"10.1016\/j.idcr.2021.e01344","article-title":"Immune thrombocytopenia relapse post COVID-19 vaccine in young male patient","volume":"26","author":"Qasim","year":"2021","journal-title":"IDCases"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2169\/internalmedicine.9177-21","article-title":"Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review","volume":"61","author":"Shonai","year":"2022","journal-title":"Intern. Med."},{"key":"ref_28","first-page":"e626","article-title":"Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine","volume":"35","author":"Krajewski","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_29","first-page":"e14853","article-title":"Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration","volume":"13","author":"Idogun","year":"2021","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12185-021-03243-2","article-title":"New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination","volume":"115","author":"Hidaka","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_31","first-page":"424","article-title":"Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination","volume":"115","author":"Saito","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11739-021-02778-w","article-title":"Immune thrombocytopenia following COVID-19 mRNA vaccine: Casuality or causality?","volume":"17","author":"Pasin","year":"2022","journal-title":"Intern. Emerg. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2021.11.030","article-title":"Detection of anti-GPIb\u03b1 autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination","volume":"209","author":"Nakamura","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-021-03235-2","article-title":"Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual","volume":"115","author":"Ogai","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"w30084","DOI":"10.4414\/SMW.2021.w30084","article-title":"Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran\u2014A clinical case and global pharmacovigilance data","volume":"151","author":"Battegay","year":"2021","journal-title":"Swiss Med. Wkly."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5603919","DOI":"10.1155\/2022\/5603919","article-title":"BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura","volume":"2022","author":"Ghosh","year":"2022","journal-title":"Case Rep. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e01245","DOI":"10.1016\/j.idcr.2021.e01245","article-title":"Immune thrombocytopenia associated with Pfizer-BioNTech\u2019s BNT162b2 mRNA COVID-19 vaccine","volume":"25","author":"Akiyama","year":"2021","journal-title":"IDCases"},{"key":"ref_38","first-page":"e16871","article-title":"Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female","volume":"13","author":"Jasaraj","year":"2021","journal-title":"Cureus"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1097\/MJT.0000000000001393","article-title":"Immune Thrombocytopenic Purpura Associated With Pfizer-BioNTech COVID-19 Vaccine Refractory to Conventional Treatment","volume":"28","author":"Ghous","year":"2021","journal-title":"Am. J. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1097\/MJT.0000000000001447","article-title":"Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia","volume":"28","author":"Abuhelwa","year":"2021","journal-title":"Am. J. Ther."},{"key":"ref_41","first-page":"6013321","article-title":"Immune Thrombocytopenia following COVID-19 Vaccine","volume":"2022","author":"Prasad","year":"2022","journal-title":"Case Rep. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/09537104.2022.2044463","article-title":"Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura","volume":"33","author":"Chanut","year":"2022","journal-title":"Platelets"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/JBM.S307047","article-title":"Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine","volume":"12","author":"Helms","year":"2021","journal-title":"J. Blood Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"395.e1","DOI":"10.1016\/j.ajem.2022.03.030","article-title":"Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor","volume":"56","author":"Chong","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"ref_45","first-page":"e14099","article-title":"Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.annemergmed.2021.02.011","article-title":"Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine","volume":"77","author":"Julian","year":"2021","journal-title":"Ann. Emerg. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1002\/ajh.26128","article-title":"Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine","volume":"96","author":"Toom","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e242678","DOI":"10.1136\/bcr-2021-242678","article-title":"Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine","volume":"14","author":"Hines","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1111\/jog.14978","article-title":"Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination","volume":"47","author":"Bennett","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_50","unstructured":"Centers for Disease Control and Prevention (2022). COVID Data Tracker, US Department of Health and Human Services, CDC. Available online: https:\/\/covid.cdc.gov\/covid-data-tracker."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1473-3099(22)00054-8","article-title":"Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: An observational study of reports to the Vaccine Adverse Event Reporting System and v-safe","volume":"22","author":"Rosenblum","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: A review of reported cases","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/S0264-410X(03)00271-8","article-title":"Unintended events following immunization with MMR: A systematic review","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children","volume":"9","author":"Cecinati","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: A systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: Basic concepts","volume":"28","author":"Watad","year":"2017","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","article-title":"Safety of antisense oligonucleotide and siRNA-based therapeutics","volume":"22","author":"Chi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_58","first-page":"8","article-title":"Shared Autoimmunity: A Case Series of 56 Patients with Immune Thrombocytopenia (ITP) Associated with Other Autoimmune Disorders","volume":"3","author":"Canals","year":"2016","journal-title":"Open Access Libr. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.17645","article-title":"Exacerbation of immune thrombocytopenia following COVID-19 vaccination","volume":"195","author":"Kuter","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","article-title":"First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"27","author":"Simpson","year":"2021","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients with Persistent Low Platelet Counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/rth2.12423","article-title":"Second-line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records","volume":"4","author":"Lal","year":"2020","journal-title":"Res. Pract. Thromb. Haemostasis."},{"key":"ref_64","unstructured":"Grady, D.M. (New York Times, 2021). Death of a doctor who got Covid shot is being investigated, New York Times."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"39","author":"Welsh","year":"2021","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1016\/j.vaccine.2021.10.030","article-title":"Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia","volume":"39","author":"Gordon","year":"2021","journal-title":"Vaccine"},{"key":"ref_68","first-page":"n1931","article-title":"Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: Self-controlled case series study","volume":"374","author":"Patone","year":"2021","journal-title":"BMJ"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/9\/1444\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:21:59Z","timestamp":1760142119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/9\/1444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["vaccines10091444"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10091444","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}